American Well Corp
NYSE:AMWL
American Well Corp
NYSE:AMWL
Price:
0.4889 USD
0.56%
Market Closed
Updated:
May 18, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
0.7
Current
-1.7
Median
13.1
Industry
Higher
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=0.7
Enterprise Value
/
-163.8m
EBITDA
-231.2m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| US |
|
American Well Corp
NYSE:AMWL
|
144.8m USD | 0.7 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
33.9B USD | 64.7 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 19.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 16.5 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
12.2B AUD | 120.5 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 12.9 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
5.2B USD | 24.5 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
4.6B USD | -126.5 | |
| SE |
|
Sectra AB
STO:SECT B
|
45.6B SEK | -70.8 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 37.3 | |
| US |
|
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | 264.4 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
hidden
2-Years Forward
EV/EBITDA
hidden
3-Years Forward
EV/EBITDA
hidden
You don't have any saved screeners yet
